Gene · 708
Papers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,121 to 2,140 of 2,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. | J Biol Chem | 1996 | 8900153 | Swiss-Prot, curated | PubMed |
| Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q. | J Immunol | 1996 | 8892652 | PubTator, text mining | PubMed |
| Human C1q induces eosinophil migration. | Clin Immunol Immunopathol | 1996 | 8808641 | PubTator, text mining | PubMed |
| Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. | J Am Soc Nephrol | 1996 | 8724891 | PubTator, text mining | PubMed |
| Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). | Proc Natl Acad Sci U S A | 1996 | 8710908 | Swiss-Prot, curated | PubMed |
| Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. | J Immunol | 1996 | 8666822 | PubTator, text mining | PubMed |
| Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. | J Biol Chem | 1996 | 8662673 | Swiss-Prot, curated | PubMed |
| Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. | Am J Hematol | 1996 | 8638610 | PubTator, text mining | PubMed |
| In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32. | J Biol Chem | 1996 | 8626563 | PubTator, text mining | PubMed |
| A nuclear envelope-associated kinase phosphorylates arginine-serine motifs and modulates interactions between the lamin B receptor and other nuclear proteins. | J Biol Chem | 1996 | 8626534 | PubTator, text mining | PubMed |
| Cell cycle regulation of nuclear factor p32 DNA-binding activity by novel phase-specific inhibitors. | J Biol Chem | 1996 | 8621580 | PubTator, text mining | PubMed |
Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2. | J Biol Chem | 1996 | 8567680 | Swiss-Prot, curated | PubMed |
| Inhibition of platelet aggregation by an SLE-derived human hybridoma autoantibody against an activation-dependent antigen. | Thromb Haemost | 1995 | 8560428 | PubTator, text mining | PubMed |
| Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. | Mol Cell Biol | 1995 | 7791793 | PubTator, text mining | PubMed |
| Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. | Virology | 1995 | 7778269 | PubTator, text mining | PubMed |
| Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. | J Virol | 1995 | 7745704 | PubTator, text mining | PubMed |
| Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. | J Clin Invest | 1995 | 7706463 | PubTator, text mining | PubMed |
| Regulation of the function of the first component of complement by human C1q receptor. | Eur J Immunol | 1995 | 7664783 | PubTator, text mining | PubMed |
| Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. | J Immunol | 1995 | 7650391 | PubTator, text mining | PubMed |
| Varicella-zoster virus assembly protein p32/p36 is present in DNA-containing as well as immature capsids. | J Med Virol | 1995 | 7636502 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/papers?page=107